A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

NCT01225081 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients

NCT01054092 ·Status: COMPLETED ·Phase: PHASE3

A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus

NCT02897219 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin

NCT00768105 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

NCT01242202 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

NCT01242215 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

NCT01242228 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients

NCT01672762 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

NCT05694741 ·Status: TERMINATED ·Phase: PHASE1

Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes

NCT00856908 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients

NCT01316107 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus

NCT02529449 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin

NCT00774553 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

NCT00817778 ·Status: COMPLETED ·Phase: PHASE2

Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults

NCT01042106 ·Status: COMPLETED ·Phase: PHASE1

To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes

NCT01176097 ·Status: COMPLETED ·Phase: PHASE1

Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study

NCT01956305 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol

NCT01099839 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes

NCT00184561 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes

NCT00747175 ·Status: COMPLETED ·Phase: PHASE1

Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)

NCT02935712 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea

NCT00995787 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

NCT01514838 ·Status: TERMINATED ·Phase: PHASE3

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.

NCT06579105 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

NCT00039013 ·Status: COMPLETED ·Phase: PHASE3